Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 May;65(5):781–782. doi: 10.1038/bjc.1992.166

Clinical correlation of high activity dynamic hepatic scintigraphy in patients with colorectal cancer.

D M Hemingway 1, T G Cooke 1, G McCurrach 1, R G Bessent 1, R Carter 1, J H McKillop 1, C S McArdle 1
PMCID: PMC1977371  PMID: 1586609

Abstract

The hepatic perfusion index, the ratio of hepatic arterial to total liver blood flow, was measured in 50 consecutive patients with colorectal cancer using radiolabelled colloid with high administered activity. In patients with proven liver metastases the diagnostic sensitivity of the HPI was 96% and the predictive value of a negative test was 92%. Dynamic hepatic scintigraphy is of value in the management of patients with colorectal cancer.

Full text

PDF
781

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BREEDIS C., YOUNG G. The blood supply of neoplasms in the liver. Am J Pathol. 1954 Sep-Oct;30(5):969–977. [PMC free article] [PubMed] [Google Scholar]
  2. Ballantyne K. C., Charnley R. M., Perkins A. C., Pye G., Whalley D. R., Wastie M. L., Hardcastle J. D. Hepatic perfusion index in the diagnosis of overt metastatic colorectal cancer. Nucl Med Commun. 1990 Jan;11(1):23–28. doi: 10.1097/00006231-199001000-00005. [DOI] [PubMed] [Google Scholar]
  3. Goldberg J. A., Fenner J., Bessent R. G., Bradnam M. S., McKillop J. H., McKee R. F., McArdle C. S., Kerr D. J. Clinical evaluation of angiotensin II enhanced perfusion scintigraphy in metastatic liver disease. Nucl Med Commun. 1989 Aug;10(8):557–566. doi: 10.1097/00006231-198908010-00004. [DOI] [PubMed] [Google Scholar]
  4. Hemingway D. M., Cooke T. G., Grime S. J., Nott D. M., Jenkins S. A. Changes in hepatic haemodynamics and hepatic perfusion index during the growth and development of hypovascular HSN sarcoma in rats. Br J Surg. 1991 Mar;78(3):326–330. doi: 10.1002/bjs.1800780319. [DOI] [PubMed] [Google Scholar]
  5. Hemingway D. M., McCurrach G., Bessent R. G., McKillop J. H., Cooke T. G. Dynamic hepatic scintigraphy: the effect of using high administered activity on reproducibility of hepatic perfusion index value. Nucl Med Commun. 1991 Sep;12(9):811–816. [PubMed] [Google Scholar]
  6. Leng B., O'Driscoll M. P., Majeed F. A., Grime J. S., Critchley M. Hepatic perfusion index in cirrhotic livers--investigation of imaging and analytical procedures. Nucl Med Commun. 1987 Dec;8(12):1001–1010. doi: 10.1097/00006231-198712000-00009. [DOI] [PubMed] [Google Scholar]
  7. Perkins A. C., Whalley D. R., Ballantyne K. C., Hardcastle J. D. Reliability of the hepatic perfusion index for the detection of liver metastases. Nucl Med Commun. 1987 Dec;8(12):982–989. doi: 10.1097/00006231-198712000-00006. [DOI] [PubMed] [Google Scholar]
  8. Taylor I., Machin D., Mullee M., Trotter G., Cooke T., West C. A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg. 1985 May;72(5):359–363. doi: 10.1002/bjs.1800720509. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES